Roivant Sciences Ltd.
ROIV · NASDAQ · USD
$35.44
+1.23 3.60%todayNot financial advice.
- Open
- 34.24
- Day range
- 34.15 - 35.59
- 52-week range
- 15.99 - 42.50
- Volume
- 5.53M
- Market cap
- 25.6B
- P/E ratio
- —
- EPS
- -0.38
- Dividend yield
- 0.00%
- Beta
- 0.59
Performance
W
−0.48%
1M
−14.38%
3M
−3.72%
6M
+24.44%
YTD
+63.24%
Y
+121.50%
5Y
+480.98%
All
+237.52%
In the news
Oct 8
Argenx Sjogrens Trial Failure Drags Down Immunovant and Roivant Shares
Argenx stopped its late-stage Sjogren’s disease trial, raising doubts about a similar drug class being developed by rival Immunovant.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-ROIV" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Roivant Sciences Ltd. (ROIV) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-ROIV">ROIV stock price</a> by FreeTheAI Stocks</p>